Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2019-01-17 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2019-01-17 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-01-11 English
10-Q
Interim / Quarterly Report Q3 2018
2018-10-30 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filing by Medpace Holdings, Inc. dated October 29, 2018. It announces the issuance of a press release regarding financial results for the three and nine months ended September 30, 2018. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release as Exhibit 99.1. The length of the document is 3511 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of financial results rather than the results themselves. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback for such announcements and filings that do not contain full financial data.
2018-10-29 English
FORM 4/A
Director's Dealing
2018-10-11 English
FORM 4/A
Director's Dealing
2018-10-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.